← Back to Clinical Trials
Recruiting NCT06039917

Effect of the Automatic Surveillance System on Surveillance Rate of Patients with Gastric Premalignant Lesions

Trial Parameters

Condition Artificial Intelligence
Sponsor Renmin Hospital of Wuhan University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 1,460
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-09-10
Completion 2028-12-31
Interventions
AI based automatic surveillance (AS) system (ENDOANGEL-AS)Manually remind the patients

Brief Summary

In this study, we proposed a prospective study about the effect of the automatic surveillance system on surveillance rate of patients with gastric premalignant lesions. The enrolled patients were divided into group A with intelligent surveillance system, group B with manual reminder, and group C with natural state. The surveillance among the three groups will be compared.

Eligibility Criteria

Inclusion Criteria: * Male or female aged 18 years or older who undergo upper endoscopy. Exclusion Criteria: * 1)No contact information or invalid contact information. * 2\) The surveillance interval cannot be determined according to the surveillance guidelines, including no upper gastrointestinal pathology, therapeutic endoscopy or with history of previous gastrectomy, esophagectomy, or ESD, no dysplasia degrees, no biopsy sites, non-epithelial lesions, duodenal lesions, ulcer and so on. * 3\) Needless for surveillance or others. * 4\) High-grade intraepithelial neoplasia or cancer of the esophagus or stomach. * 5\) Low-grade intraepithelial neoplasia of the esophagus and Barrett's esophagus. * 6\) High-risk diseases or other special conditions for which the patient is deemed unsuitable for clinical trials by the investigator.

Related Trials